News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
31,271 Results
Type
Article (1291)
Company Profile (9)
Press Release (29970)
Multimedia
Podcasts (2)
Webinars (2)
Section
Business (14493)
Career Advice (66)
Deals (1973)
Drug Delivery (5)
Drug Development (3987)
Employer Resources (11)
FDA (619)
Job Trends (1025)
News (19103)
Policy (1007)
Tag
2027 BioMidwest Standard (1)
2027 Bio NC Standard (1)
2027 Genetown Standard (1)
2027 Pharm Country Standard (1)
Academia (77)
Accelerated approval (5)
ADA (2)
Adcomms (1)
Allergies (15)
Alliances (698)
ALS (9)
Alzheimer's disease (90)
Antibody-drug conjugate (ADC) (49)
Approvals (687)
Artificial intelligence (28)
ASCO (28)
Autoimmune disease (35)
Automation (2)
Bankruptcy (5)
Belgium (1)
Best Places to Work (980)
BIOSECURE Act (1)
Biosimilars (12)
BioSpace Insights (1)
Biotechnology (4)
Bladder cancer (32)
Brain cancer (3)
Breast cancer (87)
Cancer (601)
Cardiovascular disease (37)
Career advice (50)
Career pathing (1)
CAR-T (26)
CDC (2)
CDMO (1)
Celiac Disease (1)
Cell therapy (60)
Cervical cancer (8)
Clinical research (4156)
Collaboration (76)
Commercialization (1)
Compensation (53)
Complete response letters (4)
COVID-19 (129)
CRISPR (3)
C-suite (32)
Cystic fibrosis (5)
Data (905)
Depression (11)
Dermatology (18)
Diabetes (53)
Diagnostics (343)
Digital health (4)
Diversity, equity & inclusion (8)
Drug discovery (10)
Drug pricing (7)
Drug shortages (1)
Duchenne muscular dystrophy (11)
Earnings (14775)
Editorial (1)
Employer resources (11)
Events (2562)
Executive appointments (20)
FDA (1021)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (4)
Funding (60)
Gene editing (8)
Generative AI (2)
Gene therapy (27)
GLP-1 (84)
Government (166)
Grass and pollen (1)
Guidances (163)
Healthcare (886)
Hematology (14)
HIV (5)
Huntington's disease (6)
IgA nephropathy (9)
Immunology and inflammation (16)
Immuno-oncology (2)
Indications (19)
Infectious disease (155)
Inflammatory bowel disease (12)
Inflation Reduction Act (1)
Influenza (4)
Intellectual property (9)
Interviews (15)
IPO (1571)
IRA (3)
Job creations (102)
Job search strategy (47)
Kidney cancer (3)
Kidney disease (5)
Labor market (4)
Layoffs (27)
Leadership (1)
Legal (100)
Liver cancer (6)
Lung cancer (116)
Lymphoma (75)
Machine learning (1)
Management (3)
Manufacturing (37)
MASH (34)
Medical device (734)
Medtech (760)
Mergers & acquisitions (496)
Metabolic disorders (136)
mRNA (10)
Multiple sclerosis (10)
NASH (3)
Neurodegenerative disease (17)
Neuropsychiatric disorders (4)
Neuroscience (189)
NextGen: Class of 2026 (207)
Non-profit (94)
Now hiring (5)
Obesity (53)
Opinion (8)
Ovarian cancer (16)
Pain (13)
Pancreatic cancer (27)
Parkinson's disease (22)
Patents (19)
Patient recruitment (26)
Peanut (2)
People (610)
Peptides (1)
Pharmaceutical (4)
Pharmacy benefit managers (4)
Phase 1 (843)
Phase 2 (1665)
Phase 3 (1975)
Pipeline (1648)
Policy (8)
Postmarket research (156)
Preclinical (193)
Prostate cancer (24)
Radiopharmaceuticals (16)
Rare diseases (76)
Real estate (74)
Recruiting (1)
Regulatory (1078)
Reports (9)
Research institute (82)
Resumes & cover letters (10)
Rett syndrome (4)
RSV (9)
Schizophrenia (18)
Series A (9)
Series B (6)
Service/supplier (2)
Sickle cell disease (7)
Special edition (4)
Spinal muscular atrophy (4)
Sponsored (1)
Startups (68)
Stomach cancer (2)
Supply chain (4)
Tariffs (3)
The Weekly (2)
Vaccines (58)
Venture capital (5)
Weight loss (39)
Women's health (9)
Date
Today (10)
Last 7 days (37)
Last 30 days (121)
Last 365 days (2483)
2026 (1815)
2025 (2418)
2024 (2502)
2023 (2676)
2022 (2977)
2021 (2993)
2020 (2756)
2019 (1869)
2018 (1609)
2017 (1242)
2016 (927)
2015 (1198)
2014 (767)
2013 (477)
2012 (582)
2011 (631)
2010 (592)
Location
Africa (16)
Alabama (1)
Arizona (14)
Asia (1928)
Australia (174)
California (1150)
Canada (291)
China (125)
Colorado (62)
Connecticut (42)
Delaware (58)
Europe (4957)
Florida (173)
Georgia (68)
Illinois (88)
India (3)
Indiana (73)
Japan (52)
Kansas (2)
Kentucky (2)
Louisiana (8)
Maine (13)
Maryland (124)
Massachusetts (701)
Michigan (22)
Minnesota (79)
Missouri (10)
Montana (4)
Nevada (9)
New Hampshire (9)
New Jersey (462)
New Mexico (1)
New York (279)
North Carolina (147)
Northern California (612)
Ohio (50)
Oregon (10)
Pennsylvania (232)
Puerto Rico (1)
South America (54)
South Carolina (4)
Southern California (474)
Tennessee (16)
Texas (161)
United States (4113)
Utah (34)
Virginia (19)
Washington D.C. (8)
Washington State (71)
Wisconsin (8)
Wyoming (1)
31,271 Results for "62".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
TwoStep Therapeutics Announces Oversubscribed $62.5 Million Series A Financing and FDA Clearance of IND for First-in-Class Peptide-Drug Conjugate
September 9, 2026
·
5 min read
Press Releases
SAB BIO to Present SAB-142 Data at the 62nd Annual Meeting of the European Association for the Study of Diabetes
September 22, 2026
·
6 min read
Press Releases
MitoRx Therapeutics to present new data on MTRX31, its novel mitochondrial-targeted small molecule, at the 62nd EASD Annual Meeting 2026
September 17, 2026
·
2 min read
Press Releases
QUVIVIQ sales increased 62% year-on-year as Idorsia advances key drivers of future growth
July 30, 2026
·
16 min read
Press Releases
Oblenio Bio Closes $62 Million Series B to Advance Tri-specific T-Cell Engager LBL-051 for Autoimmune Diseases into Clinical Development
June 25, 2026
·
3 min read
Press Releases
Oncology Ventures Announces Oversubscribed $62 Million Fund II to Accelerate the Future of Cancer Care
April 22, 2026
·
3 min read
Press Releases
TECVAYLI® + TALVEY® reduced the risk of disease progression or death by 89% and the risk of death by 62% in earlier-line relapsed/refractory multiple myeloma
July 23, 2026
·
32 min read
Press Releases
Neurent Medical Raises €62.5 million in Oversubscribed Series C Financing to Accelerate NEUROMARK® Commercial Expansion to treat Chronic Rhinitis
February 12, 2026
·
4 min read
Press Releases
Ascletis Announces Oral Discussion of ASC36_35 FDC Preclinical Data Demonstrating Superior Weight Loss to Eloralintide/Tirzepatide Combination at the 62nd European Association for the Study of Diabetes (EASD) Annual Meeting
July 23, 2026
·
3 min read
Press Releases
Leads Biolabs Announces Partner Oblenio Bio’s $62 Million Oversubscribed Series B Financing to Advance Tri-Specific T-Cell Engager LBL‑051 for Autoimmune Diseases into Clinical Development
June 25, 2026
·
3 min read
1 of 3,128
Next
